Objective Universal screening for cytomegalovirus (CMV) infection in pregnancy is not
recommended in most countries. One of the major deterrents is the lack of effective prenatal …

Objective Recent studies have shown that a dosage of 8 g/d of oral valacyclovir reduces
substantially the vertical transmission rate of cytomegalovirus in women with primary …

BACKGROUND Valacyclovir is the only treatment demonstrated to be effective for the
prevention of vertical transmission of cytomegalovirus within a clinical randomized, placebo …

Objective Congenital cytomegalovirus (CMV) infection is the leading cause of non‐genetic
hearing and neurological deficits. The aim of our study was to evaluate the efficacy and …

Pregnancy after thoracic organ transplantation is feasible for select individuals but requires
multidisciplinary subspecialty care. Key components for a successful pregnancy after lung or …

Cytomegalovirus (CMV) is the most common cause of congenital infections in developed
countries because is capable of infecting the fetus after both primary and recurrent maternal …

Background Congenital cytomegalovirus (cCMV) is the most common congenital infection
worldwide. cCMV can lead to severe long‐term sequelae, including neurological impairment …

Abstract Background Human Cytomegalovirus (HCMV) is the most frequent congenital
infection worldwide causing important sequelae. However, no vaccine or antiviral treatments …

Introduction Congenital CMV infection is the first worldwide cause of congenital viral
infection but systematic screening of pregnant women and newborns for CMV is still debated …

Cytomegalovirus (CMV) is the leading infectious cause of congenital neurological
disabilities. Valacyclovir and CMV hyperimmune globulin (HIG) may reduce vertical …